Advances in the applications of polyhydroxyalkanoate nanoparticles for novel drug delivery system

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Shrivastav, Anupama ^a   Kim, Hae Yeong ^a   Kim, Young Rok ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; DRUG CARRIER; MICROSPHERE; NANOPARTICLE; POLYHYDROXYALKANOIC ACID; PREDNISOLONE; RUBOMYCIN; TETRACYCLINE; VACCINE; BIOMATERIAL;

BIOCOMPATIBILITY; BIODEGRADABILITY; BIOSYNTHESIS; CUPRIAVIDUS NECATOR; DRUG DELIVERY SYSTEM; ENERGY RESOURCE; ENZYMATIC DEGRADATION; HUMAN; INDUSTRIAL PRODUCTION; MICROCAPSULE; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL CHEMISTRY; POLYMERIZATION; REVIEW; SUSTAINED DRUG RELEASE; BIOREMEDIATION; CHEMISTRY; ULTRASTRUCTURE;

BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; POLYHYDROXYALKANOATES;

EID: 84881532981     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/581684     Document Type: Review

References (69)

1. Cammas S., Béar M.-M., Moine L., Escalup R., Ponchel G., Kataoka K., Guérin P., Polymers of malic acid and 3-alkylmalic acid as synthetic PHAs in the design of biocompatible hydrolyzable devices. International Journal of Biological Macromolecules 1999 25 1-3 273 282 2-s2.0-0345711678 10.1016/S0141-8130(99)00042-2 (Pubitemid 29302007)
2. Lee S. Y., Chang H. N., Production of poly(3-hydroxybutyric acid) by recombinant Escherichia coli strains: genetic and fermentation studies. Canadian Journal of Microbiology 1995 41 1 207 215 2-s2.0-0029125406
3. Lemoigne M., Produits de deshydration et de polymerisation de lacide β -oxybutyrique. Bulletin de la Societe de Chimie Biologique 1926 8 770 782
4. Madison L. L., Huisman G. W., Metabolic engineering of poly(3-hydroxyalkanoates): from DNA to plastic. Microbiology and Molecular Biology Reviews 1999 63 1 21 53 2-s2.0-0033046562 (Pubitemid 29116086)
5. Griebel R., Smith Z., Merrick J. M., Metabolism of Poly- β -hydroxybutyrate. I. Purification, composition, and properties of native poly- β -hydroxybutyrate granules from bacillus megaterium. Biochemistry 1968 7 10 3676 3681 2-s2.0-0014340156
6. Errico C., Bartoli C., Chiellini F., Chiellini E., Poly(hydroxyalkanoates)-based polymeric nanoparticles for drug delivery. Journal of Biomedicine and Biotechnology 2009 2009 10 2-s2.0-70350006838 10.1155/2009/571702 571702
7. Chen G.-Q., A microbial polyhydroxyalkanoates (PHA) based bio- and materials industry. Chemical Society Reviews 2009 38 8 2434 2446 2-s2.0-69249092516 10.1039/b812677c
8. Steinbüchel A., Füchtenbusch B., Bacterial and other biological systems for polyester production. Trends in Biotechnology 1998 16 10 419 427 2-s2.0-0042344160 10.1016/S0167-7799(98)01194-9 (Pubitemid 28484811)
9. Steinbuchel A., Schlegel H. G., Physiology and molecular genetics of poly(β -hydroxy-alkanoic acid) synthesis in Alcaligenes eutrophus. Molecular Microbiology 1991 5 3 535 542 2-s2.0-0026033649 (Pubitemid 21896075)
10. Keshavarz T., Roy I., Polyhydroxyalkanoates: bioplastics with a green agenda. Current Opinion in Microbiology 2010 13 3 321 326 2-s2.0-77952955154 10.1016/j.mib.2010.02.006
11. Kessler B., Witholt B., Factors involved in the regulatory network of polyhydroxyalkanoate metabolism. Journal of Biotechnology 2001 86 2 97 104 2-s2.0-0035970990 10.1016/S0168-1656(00)00404-1 (Pubitemid 32195451)
12. Poirier Y., Nawrath C., Somerville C., Production of polyhydroxyalkanoates, a family of biodegradable plastics and elastomers, in bacteria and plants. Bio/Technology 1995 13 2 142 150 2-s2.0-0028891191
13. Anderson A. J., Dawes E. A., Occurrence, metabolism, metabolic role, and industrial uses of bacterial polyhydroxyalkanoates. Microbiological Reviews 1990 54 4 450 472 2-s2.0-0025226099 (Pubitemid 120004382)
14. Nobes G. A. R., Marchessault R. H., Maysinger D., Polyhydroxyalkanoates: materials for delivery systems. Drug Delivery 1998 5 3 167 177 2-s2.0-0031706291 (Pubitemid 28449938)
15. Shah M., Ullah N., Choi M. H., Kim M. O., Yoon S. C., Amorphous amphiphilic P(3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester via melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and in vitro evaluation. European Journal of Pharmaceutics and Biopharmaceutics 2012 80 3 518 527 2-s2.0-84858156521 10.1016/j.ejpb.2011.11.014
16. Byrom D., Polymer synthesis by microorganisms: technology and economics. Trends in Biotechnology 1987 5 9 246 250 2-s2.0-0023416746 (Pubitemid 18533373)
17. Doi Y., Kanesawa Y., Kunioka M., Saito T., Biodegradation of microbial copolyesters: poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and poly(3-hydroxybutyrate-co-4-hydroxybutyrate). Macromolecules 1990 23 1 26 31 2-s2.0-0025702697 (Pubitemid 20637044)
18. Saito Y., Doi Y., Microbial synthesis and properties of poly(3-hydroxybutyrate-co-4-hydroxybutyrate) in Comamonas acidovorans. International Journal of Biological Macromolecules 1994 16 2 99 104 2-s2.0-0028346012 10.1016/0141-8130(94)90022-1 (Pubitemid 24123450)
19. Sudesh K., Abe H., Doi Y., Synthesis, structure and properties of polyhydroxyalkanoates: biological polyesters. Progress in Polymer Science 2000 25 10 1503 1555 2-s2.0-0034501647 10.1016/S0079-6700(00)00035-6 (Pubitemid 32029920)
20. Pişkin E., Biodegradable polymers as biomaterials. Journal of Biomaterials Science-Polymer 1995 6 9 775 795 2-s2.0-0029194884
21. Mukai K., Doi Y., Sema Y., Tomita K., Substrate specificities in hydrolysis of polyhydroxyalkanoates by microbial esterases. Biotechnology Letters 1993 15 6 601 604 2-s2.0-0027293097 (Pubitemid 23204469)
22. Löbler M., Sass M., Michel P., Hopt U. T., Kunze C., Schmitz K.-P., Differential gene expression after implantation of biomaterials into rat gastrointestine. Journal of Materials Science 1999 10 12 797 799 2-s2.0-0033386628 10.1023/A:1008959204218 (Pubitemid 30064203)
23. Zinn M., Witholt B., Egli T., Occurrence, synthesis and medical application of bacterial polyhydroxyalkanoate. Advanced Drug Delivery Reviews 2001 53 1 5 21 2-s2.0-0035803751 10.1016/S0169-409X(01)00218-6 (Pubitemid 33152831)
24. Reusch R. N., Poly- β -hydroxybutyrate/calcium polyphosphate complexes in eukaryotic membranes. Proceedings of the Society for Experimental Biology and Medicine 1989 191 4 377 381 2-s2.0-0024469063 (Pubitemid 19253900)
25. Chen G.-Q., Wu Q., The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials 2005 26 33 6565 6578 2-s2.0-22544467008 10.1016/j.biomaterials.2005.04.036 (Pubitemid 41021750)
26. Valappil S. P., Misra S. K., Boccaccini A., Roy I., Biomedical applications of polyhydroxyalkanoates, an overview of animal testing and in vivo responses. Expert Review of Medical Devices 2006 3 6 853 868 2-s2.0-33845872800 10.1586/17434440.3.6.853 (Pubitemid 46017624)
27. Hazer B., Amphiphilic poly(3-hydroxy alkanoate)s: potential candidates for medical applications. International Journal of Polymer Science 2010 2010 8 423460 10.1155/2010/423460
28. Misra S. K., Valappil S. P., Roy I., Boccaccini A. R., Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue engineering applications. Biomacromolecules 2006 7 8 2249 2258 2-s2.0-33748368301 10.1021/bm060317c (Pubitemid 44336334)
29. Wu Q., Wang Y., Chen G.-Q., Medical application of microbial biopolyesters polyhydroxyalkanoates. Artificial Cells, Blood Substitutes, and Biotechnology 2009 37 1 1 12 2-s2.0-61649126031 10.1080/10731190802664429
30. Shishatskaya E. I., Volova T. G., A comparative investigation of biodegradable polyhydroxyalkanoate films as matrices for in vitro cell cultures. Journal of Materials Science 2004 15 8 915 923 2-s2.0-4043062865 10.1023/B:JMSM.0000036280.98763.c1 (Pubitemid 39070219)
31. Wei X., Hu Y.-J., Xie W.-P., Lin R.-L., Chen G.-Q., Influence of poly(3-hydroxybutyrate-co-4-hydroxybutyrate-co-3-hydroxyhexanoate) on growth and osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Journal of Biomedical Materials Research A 2009 90 3 894 905 2-s2.0-73249123143
32. Ji G.-Z., Wei X., Chen G.-Q., Growth of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on the terpolyester poly(3-hydroxybutyrate- co-3-hydroxyvalerate-co-3- hydroxyhexanoate). Journal of Biomaterials Science-Polymer 2009 20 3 325 339 2-s2.0-59649122881 10.1163/156856209X412191
33. Sevastianov V. I., Perova N. V., Shishatskaya E. I., Kalacheva G. S., Volova T. G., Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood. Journal of Biomaterials Science-Polymer 2003 14 10 1029 1042 2-s2.0-0242332359 10.1163/156856203769231547 (Pubitemid 37361320)
34. Brigham C. J., Sinskey A. J., Applications of polyhydroxyalkanoates in the medical industry. International Journal of Biotechnology For Wellness Industries 2012 1 1 53 60
35. Korsatko W., Wabnegg B., Tillian H. M., Poly-D-(-)-3-hydroxybutyric acid: a biodegradable carrier for long term medication dosage. II. Comm.: the biodegradation in animal organism and in-vitro-in-vivo correlation of the liberation of pharmaceuticals from parenteral matrix retard tablets. Pharmazeutische Industrie 1983 45 10 1004 1007 2-s2.0-0021081848 (Pubitemid 14232629)
36. Ciardelli G., Saad B., Hirt T., Keiser O., Neuenschwander P., Suter U. W., Uhlschmid G. K., Phagocytosis and biodegradation of short-chain poly [(R)-3-hydroxybutyric acid] particles in macrophage cell line. Journal of Materials Science 1995 6 12 725 730 2-s2.0-0029559348 10.1007/BF00134308 (Pubitemid 26014582)
37. Pouton C. W., Akhtar S., Biosynthetic polyhydroxyalkanoates and their potential in drug delivery. Advanced Drug Delivery Reviews 1996 18 2 133 162 2-s2.0-0029671369 10.1016/0169-409X(95)00092-L
38. Juni K., Nakano M., Poly(hydroxy acids) in drug delivery. Critical Reviews in Therapeutic Drug Carrier Systems 1987 3 3 209 232 2-s2.0-0023151716 (Pubitemid 17021224)
39. Pouton C. W., Kennedy J. E., Notarianni L. J., Gould P. L., Biocompatibility of polyhydroxy-butyrate and related copolymers. 15 Proceedings of the International Symposium on Controlled Release Bioactive Materials 1988 179 180
40. Lenz R. W., Marchessault R. H., Bacterial polyesters: biosynthesis, biodegradable plastics and biotechnology. Biomacromolecules 2005 6 1 1 8 2-s2.0-14044254667 10.1021/bm049700c (Pubitemid 40276990)
41. Nobes G. A. R., Marchessault R. H., Maysinger D., Polyhydroxyalkanoates: materials for delivery systems. Drug Delivery 1998 5 3 167 177 2-s2.0-0031706291 (Pubitemid 28449938)
42. Orts W. J., Nobes G. A. R., Kawada J., Nguyen S., Yu G.-E., Ravenelle F., Poly(hydroxyalkanoates): biorefinery polymers with a whole range of applications. The work of Robert H. Marchessault. Canadian Journal of Chemistry 2008 86 6 628 640 2-s2.0-44949261921 10.1139/V08-050
43. Gangrade N., Price J. C., Poly(hydroxybutyrate-hydroxyvalerate) microspheres containing progesterone: preparation, morphology and release properties. Journal of Microencapsulation 1991 8 2 185 202 2-s2.0-0025776971
44. Gould P. L., Holland S. J., Tighe B. J., Polymers for biodegradable medical devices. IV. Hydroxybutyrate-valerate copolymers as non-disintegrating matrices for controlled-release oral dosage forms. International Journal of Pharmaceutics 1987 38 231 237 2-s2.0-0023639208 (Pubitemid 17148774)
45. Gursel I., Yagmurlu F., Korkusuz F., Hasirci V., In vitro antibiotic release from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) rods. Journal of Microencapsulation 2002 19 2 153 164 2-s2.0-0036153894 10.1080/02652040110065413 (Pubitemid 34100608)
46. Yagmurlu M. F., Korkusuz F., Gursel I., Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: in vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis. Journal of Biomedical Materials Research 1999 46 4 494 503
47. Türesin F., Gürsel I., Hasirci V., Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release. Journal of Biomaterials Science-Polymer 2001 12 2 195 207 2-s2.0-0034982020 10.1163/156856201750180924 (Pubitemid 32515007)
48. Gürsel I., Korkusuz F., Türesin F., Gürdal Alaeddinolu N., Hasirci V., In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. Biomaterials 2001 22 1 73 80 2-s2.0-0035239053 10.1016/S0142-9612(00)00170-8
49. Bissery M. C., Valeriote F. A., Thies C., Therapeutic efficacy of CCNU-loaded microspheres prepared from poly (D,L) lactide (PLA) or poly-B-hydroxybutyrate (PHB) against Lewis lung (LL) carcinoma. Proceedings of the American Association for Cancer Research 1985 26 355 2-s2.0-0021908211
50. Kubota M., Nakano M., Juni K., Mechanism of enhancement of the release rate of aclarubicin from poly- β -hydroxybutyric acid microspheres by fatty acid esters. Chemical and Pharmaceutical Bulletin 1988 36 1 333 337 2-s2.0-0023860068 (Pubitemid 18073401)
51. Sendil D., Gürsel I., L. Wise D., Hasirci V., Antibiotic release from biodegradable PHBV microparticles. Journal of Controlled Release 1999 59 2 207 217 2-s2.0-0345379619 10.1016/S0168-3659(98)00195-3 (Pubitemid 29199926)
52. Shishatskaya E. I., Goreva A. V., Voinova O. N., Inzhevatkin E. V., Khlebopros R. G., Volova T. G., Evaluation of antitumor activity of rubomycin deposited in absorbable polymeric microparticles. Bulletin of Experimental Biology and Medicine 2008 145 3 358 361 2-s2.0-50649118059 10.1007/s10517-008- 0091-9
53. Koosha F., Muller R. H., Davis S. S., A continuous flow system for in vitro evaluation of drug-loaded biodegradable colloidal barriers. Journal of Pharmacy and Pharmacology 1988 40 131
54. Kawaguchi T., Tsugane A., Higashide K., Endoh H., Hasegawa T., Kanno H., Seki T., Juni K., Fukushima S., Nakano M., Control of drug release with a combination of prodrug and polymer matrix: antitumor activity and release profiles of 2',3'-diacyl-5-fluoro-2'-deoxyuridine from poly(3-hydroxybutyrate) microspheres. Journal of Pharmaceutical Sciences 1992 81 6 508 512 2-s2.0-0026779331 10.1002/jps.2600810606
55. Lu X.-Y., Ciraolo E., Stefenia R., Chen G.-Q., Zhang Y., Hirsch E., Sustained release of PI3K inhibitor from PHA nanoparticles and in vitro growth inhibition of cancer cell lines. Applied Microbiology and Biotechnology 2011 89 5 1423 1433 2-s2.0-79952574593 10.1007/s00253-011-3101-1
56. Peters V., Rehm B. H. A., In vivo monitoring of PHA granule formation using GFP-labeled PHA synthases. FEMS Microbiology Letters 2005 248 1 93 100 2-s2.0-20444498924 10.1016/j.femsle.2005.05.027 (Pubitemid 40828319)
57. Peters V., Rehm B. H. A., In vivo enzyme immobilization by use of engineered polyhydroxyalkanoate synthase. Applied and Environmental Microbiology 2006 72 3 1777 1783 2-s2.0-33644961915 10.1128/AEM.72.3.1777-1783.2006
58. Jahns A. C., Haverkamp R. G., Rehm B. H. A., Multifunctional inorganic-binding beads self-assembled inside engineered bacteria. Bioconjugate Chemistry 2008 19 10 2072 2080 2-s2.0-55249108919 10.1021/bc8001979
59. Kim Y.-R., Paik H.-J., Ober C. K., Coates G. W., Batt C. A., Enzymatic surface-initiated polymerization: a novel approach for the in situ solid-phase synthesis of biocompatible polymer pol(3-hydroxybutyrate). Biomacromolecules 2004 5 3 889 894 2-s2.0-2542533771 10.1021/bm0344147 (Pubitemid 38702262)
60. Paik H.-J., Kim Y.-R., Orth R. N., Ober C. K., Coates G. W., Batt C. A., End-functionalization of poly(3-hydroxybutyrate) via genetic engineering for solid surface modification. Chemical Communications 2005 15 1956 1958 2-s2.0-18044368874 10.1039/b415809a (Pubitemid 40604489)
61. Yao Y.-C., Zhan X.-Y., Zhang J., Zou X.-H., Wang Z.-H., Xiong Y.-C., Chen J., Chen G.-Q., A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands. Biomaterials 2008 29 36 4823 4830 2-s2.0-53449083912 10.1016/j.biomaterials.2008.09.008
62. Zhang C., Zhao L. Q., Dong Y. F., Zhang X. Y., Lin J., Chen Z., Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 2010 76 1 10 16 2-s2.0-77955653673 10.1016/j.ejpb.2010.05.005
63. Lee J., Jung S.-G., Park C.-S., Kim H.-Y., Batt C. A., Kim Y.-R., Tumor-specific hybrid polyhydroxybutyrate nanoparticle: surface modification of nanoparticle by enzymatically synthesized functional block copolymer. Bioorganic and Medicinal Chemistry Letters 2011 21 10 2941 2944 2-s2.0-79955556094 10.1016/j.bmcl.2011.03.058
64. Yamamoto H., Kuno Y., Sugimoto S., Takeuchi H., Kawashima Y., Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. Journal of Controlled Release 2005 102 2 373 381 2-s2.0-11844282711 10.1016/j.jconrel.2004.10.010 (Pubitemid 40093760)
65. Bartlett D. W., Su H., Hildebrandt I. J., Weber W. A., Davis M. E., Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proceedings of the National Academy of Sciences of the United States of America 2007 104 39 15549 15554 2-s2.0-34848918210 10.1073/pnas.0707461104 (Pubitemid 47502954)
66. Pirollo K. F., Chang E. H., Does a targeting ligand influence nanoparticle tumor localization or uptake? Trends in Biotechnology 2008 26 10 552 558 2-s2.0-51249122212 10.1016/j.tibtech.2008.06.007
67. Shi J., Votruba A. R., Farokhzad O. C., Langer R., Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Letters 2010 10 9 3223 3230 2-s2.0-77956434412 10.1021/nl102184c
68. Eldridge J. H., Hammond C. J., Meulbroek J. A., Staas J. K., Gilley R. M., Tice T. R., Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. Journal of Controlled Release 1990 11 1-3 205 214 2-s2.0-0025069886 (Pubitemid 20070098)
69. Kim H.-N., Lee J., Kim H.-Y., Kim Y.-R., Enzymatic synthesis of a drug delivery system based on polyhydroxyalkanoate-protein block copolymers. Chemical Communications 2009 46 7104 7106 2-s2.0-70450183502 10.1039/b912871a